The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis.
D000328:Adult; D000818:Animals; D000906:Antibodies; D006502:Budd-Chiari Syndrome / Q000188:drug therapy; D003168:Complement Fixation Tests; D003165:Complement System Proteins; D005260:Female; D006168:Guinea Pigs / Q000276:immunology; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy / Q000503:physiopathology*; D006461:Hemolysis; D006801:Humans; D007444:Inulin; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011817:Rabbits / Q000276:immunology; D012756:Sheep / Q000276:immunology; D012911:Snakes; D013395:Sucrose; D014688:Venoms; D014859:Warfarin / Q000627:therapeutic use
D000906:Antibodies; D014688:Venoms; D013395:Sucrose; D014859:Warfarin; D007444:Inulin; D003165:Complement System Proteins; D011239:Prednisolone